Aktis Oncology: IPO Analysis
IPO Overview Aktis Oncology is a clinical-stage radiopharmaceutical company developing targeted alpha-particle therapies for cancer treatment. Technology Platform Alpha Particles:...
1 articles, transcripts, and reports
IPO Overview Aktis Oncology is a clinical-stage radiopharmaceutical company developing targeted alpha-particle therapies for cancer treatment. Technology Platform Alpha Particles:...